A detailed history of Capstone Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 6,573 shares of BIIB stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,573
Previous 10,881 39.59%
Holding current value
$1.14 Million
Previous $2.35 Million 35.08%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $820,760 - $1.02 Million
-4,308 Reduced 39.59%
6,573 $1.52 Million
Q1 2024

May 01, 2024

BUY
$212.02 - $267.71 $1.21 Million - $1.52 Million
5,691 Added 109.65%
10,881 $2.35 Million
Q4 2023

Feb 12, 2024

SELL
$222.59 - $267.94 $158,929 - $191,309
-714 Reduced 12.09%
5,190 $1.34 Million
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $935,436 - $1.06 Million
3,693 Added 167.03%
5,904 $1.52 Million
Q2 2023

Aug 10, 2023

SELL
$275.25 - $318.06 $343,787 - $397,256
-1,249 Reduced 36.1%
2,211 $629,000
Q1 2023

May 09, 2023

BUY
$256.56 - $292.34 $887,697 - $1.01 Million
3,460 New
3,460 $961,000
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $853,119 - $1.01 Million
-4,549 Reduced 93.05%
340 $69,000
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $2.65 Million - $3.34 Million
-13,668 Reduced 73.65%
4,889 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $1.67 Million - $2.14 Million
7,438 Added 66.89%
18,557 $4.45 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $1.18 Million - $1.53 Million
4,153 Added 59.62%
11,119 $3.15 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $3.08 Million - $4.93 Million
-11,876 Reduced 63.03%
6,966 $2.41 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $3.57 Million - $5.38 Million
15,119 Added 406.1%
18,842 $4.61 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $668,014 - $771,306
-2,523 Reduced 40.39%
3,723 $1.06 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $1.54 Million - $2.04 Million
5,943 Added 1961.39%
6,246 $1.67 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $5.01 Million - $6.93 Million
-22,781 Reduced 98.69%
303 $90,000
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $1.05 Million - $1.17 Million
-4,814 Reduced 17.26%
23,084 $5.37 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $381,345 - $420,351
-1,739 Reduced 5.87%
27,898 $6.53 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $5.96 Million - $9.32 Million
27,492 Added 1281.68%
29,637 $7.01 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $331,972 - $420,478
-1,192 Reduced 35.72%
2,145 $645,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $420,012 - $549,260
1,431 Added 75.08%
3,337 $1.18 Million
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $490,833 - $584,970
1,906 New
1,906 $553,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.